20 June 2012 13:47 [Source: ICIS news]
HOUSTON (ICIS)--A ?xml:namespace>
The court’s decision means that Gevo is once again free to sell in any market, to any customer, in any region, it said.
The companies are locked in a patent dispute over the production of bio-based isobutanol.
“We are pleased that the first judicial decision in this dispute landed decisively in favour of Gevo,” said Brett Lund, Gevo executive vice president and general counsel.
Butamax said it plans to appeal the court’s ruling.
“This [court decision] is an early step in a long and complex litigation process,” said Butamax CEO Paul Beckwith.
“We remain highly confident in the ultimate outcome of this case and our other cases against Gevo,” Beckwith added.
A full trial of the case has been scheduled for April 2013, Butamax said.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|
Asian Chemical Connections